List of Excipients in API quinapril and hydrochlorothiazide 10/12.5
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing quinapril and hydrochlorothiazide 10/12.5
Detailed excipient profiles for quinapril and hydrochlorothiazide 10/12.5
Excipient focus: CROSPOVIDONE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
quinapril and hydrochlorothiazide 10/12.5 drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CARBONATE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing MAGNESIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing MAGNESIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
quinapril and hydrochlorothiazide 10/12.5 drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
quinapril and hydrochlorothiazide 10/12.5 drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | quinapril and hydrochlorothiazide 10/12.5 | 69097-828 |
| >Company | >Ingredient | >NDC |
quinapril and hydrochlorothiazide 10/12.5 drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
